The costs (despite impairments) are absurd for a company generating modest revenue that is static - what is planned to measure ROI on their marketing targets. What are the ROI benefits of magpie study in extra units per year? Has this even been modelled with existing customers? The result was so poor that I’m running out of energy with this company - since new management it’s been largely farcical.
Ann: FY24 Full Year Results Announcement Details, page-3
Add MVP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
-0.010(2.22%) |
Mkt cap ! $51.82M | |||
| Open | High | Low | Value | Volume |
| 46.0¢ | 46.0¢ | 44.0¢ | $42.82K | 95.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 23367 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 6803 | 4 |
View Market Depth
| Last trade - 12.54pm 03/10/2024 (20 minute delay) ? |
| MVP (ASX) Chart |